#$%^&*AU2018250480A120181115.pdf#####IMMUNOGENIC ANTI-INFLAMMATORY COMPOSITIONS Abstract: The invention provides methods of formulating an anti-inflammatory composition for treating inflammatory conditions in a specific organ or tissue. The method involves selecting at least one pathogen that is pathogenic in the specific organ or tissue； producing an antigenic composition comprising antigenic determinants that together are specific for the pathogen； and formulating the antigenic composition for administration as an anti-inflammatory composition capable of eliciting an anti-inflammatory response in the specific organ or tissue, wherein the condition characterized by inflammation is not a cancer. In embodiments of the invention, a cancer is situated in the specific organ or tissue. IL-1 0 16 ** (P-O012) 4I20P "SSA I S #InSA Figure 48WO 2012/012874 PCT/CA2011/000851 FIGURE 1 Cancer Lung & Bronchus Stage 3B & 4 Survival 100% 90% -- -- CIH MRV n=50 80% --- CIH NonMRV n=58 70% V 60% 50% 40%30% 20% 10% 0% 0 10 20 30 40 50 60 Time from Diagnosis in Months 1/50
